Pulmonary hypertension associated with congenital heart disease: Pulmonary vascular disease: The global perspective

Chest

Volumn 137, Issue 6 SUPPL., 2010, Pages 52S-61S

  Adatia, Ian ^a   Kothari, Shyam S ^b   Feinstein, Jeffrey A ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL PROLIFERATION; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; EISENMENGER COMPLEX; ENVIRONMENTAL FACTOR; GENETIC DIFFERENCE; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFLAMMATION; LUNG BLOOD FLOW; MEDICAL CARE; MORBIDITY; MORTALITY; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REVIEW; RISK FACTOR; RUBELLA; SHEAR STRESS; THROMBOSIS; TUBERCULOSIS; VASOCONSTRICTION;

EID: 77953302009     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2861     Document Type: Review

References (122)

1. Tefuarani N, Hawker R, Vince J, Sleigh A, Williams GM. Surgical programme at Royal Alexandra Hospital, Sydney, for Papua New Guinea children with congenital heart disease, 1978-1994. J Paediatr Child Health. 2002;38(2):178-182.
2. Butrous G, Ghofrani HA, Grimminger F. Pulmonary vascular disease in the developing world. Circulation. 2008;118(17): 1758-1766.
3. Galie N, Manes A, Palazzini M, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs. 2008;68(8):1049-1066.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors:Global Burden of Disease Study. Lancet. 1997;349(9063):1436- 1442.
5. Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet. 2009;374(9683):65-75.
6. King M, Smith A, Gracey M. Indigenous health part 2:the underlying causes of the health gap. Lancet. 2009;374(9683): 76-85.
7. Saxena A. Congenital heart disease in India:a status report. Indian J Pediatr. 2005;72(7):595-598. (Pubitemid 41176433)
8. Kumar RK, Shrivastava S. Paediatric heart care in India. Heart. 2008;94(8):984-990.
9. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37(5):1170-1175.
10. Bang AT, Bang RA;The SEARCH Team. Diagnosis of causes of childhood deaths in developing countries by verbal autopsy:suggested criteria. Bull World Health Organ. 1992;70(4):499-507.
11. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003;361(9376):2226-2234.
12. UNICEF. State of the world's children. 2001. http://www. unicef.org/sowc01/toc.htm. Accessed November 2009.
13. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S43-S54.
14. Lee S-D, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998;101(5):927-934.
15. Roberts KE, McElroy JJ, Wong WP, et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J. 2004;24(3):371-374.
16. Harrison RE, Berger R, Haworth SG, et al. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation. 2005;111(4): 435-441.
17. Kothari SS. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol. 2010;55(3):267.
18. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2): 163-172.
19. Hoffman JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol. 1995;16(3):103-113.
20. Gupta B, Antia AU. Incidence of congenital heart disease in Nigerian children. Br Heart J. 1967;29(6):906-909.
21. Ejim EC, Ike SO, Anisiuba BC, et al. Ventricular septal defects at the University of Nigeria Teaching Hospital, Enugu:a review of echocardiogram records. Trans R Soc Trop Med Hyg. 2009;103(2):159-161.
22. Antia AU. Congenital heart disease in Nigeria. Clinical and necropsy study of 260 cases. Arch Dis Child. 1974;49(1): 36-39.
23. Sulafa KM, Karani Z. Diagnosis, management and outcome of heart disease in Sudanese patients. East Afr Med J. 2007;84(9):434-440.
24. Caddell JL, Connor DH. Congenital heart disease in Ugandan children. Br Heart J. 1966;28(6):766-767.
25. Marijon E, Tivane A, Voicu S, et al. Prevalence of congenital heart disease in schoolchildren of sub-Saharan Africa, Mozambique. Int J Cardiol. 2006;113(3):440-441.
26. McLaren MJ, Lachman AS, Barlow JB. Prevalence of congenital heart disease in black schoolchildren of Soweto, Johannesburg. Br Heart J. 1979;41(5):554-558. (Pubitemid 9231133)
27. el Hag AI. Pattern of congenital heart disease in Sudanese children. East Afr Med J. 1994;71(9):580-586.
28. Shann MK. Congenital heart disease in Taiwan, Republic of China. Circulation. 1969;39(2):251-258.
29. Shah GS, Singh MK, Pandey TR, et al. Incidence of congenital heart disease in tertiary care hospital. Kathmandu Univ Med J(KUMJ). 2008;6(21):33-36.
30. Keith JD, Rose V, Collins G, Kidd BS. Ventricular septal defect. Incidence, morbidity, and mortality in various age groups. Br Heart J. 1971;33(suppl):81-87.
31. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900.
32. Muir CS. Incidence of congenital heart disease in Singapore. Br Heart J. 1960;22 :243-254.
33. Watler DC. Congenital heart disease in Jamaica. Observation on post mortem incidence, with a report of an unusual case of cor triloculare biatriatum. West Indian Med J. 1960;9 :194-200.
34. Bradlow BA, Zion MM, Fleishman SJ. Heart Disease in Africa, with Particular Reference to Southern Africa. Am J Cardiol. 1964;13 :650-669.
35. Bannerman CH, Mahalu W. Congenital heart disease in Zimbabwean children. Ann Trop Paediatr. 1998;18(1):5-12. (Pubitemid 28115940)
36. Jaiyesimi F, Ruberu DK, Misra VK. Pattern of congenital heart disease in King Fahd Specialist Hospital, Buraidah. Ann Saudi Med. 1993;13(5):407-411. (Pubitemid 23331880)
37. Alabdulgader AA. Congenital heart disease in 740 subjects: epidemiological aspects. Ann Trop Paediatr. 2001;21(2): 111-118. (Pubitemid 32655050)
38. Akang EE, Osinusi KO, Pindiga HU, Okpala JU, Aghadiuno PU. Congenital malformations:a review of 672 autopsies in Ibadan, Nigeria. Pediatr Pathol. 1993;13(5):659-670.
39. Kokou O, AgbèrèAR, Balaka B, et al. The use of Doppler echocardiography in the diagnosis of congenital heart disease in the Pediatric Department of CHU-Tokoin, at Lomé (Togo) [In French]. Sante. 1996;6(3):161-164.
40. Asani MO, Sani MU, Karaye KM, Adeleke SI, Baba U. Structural heart diseases in Nigerian children. Niger J Med. 2005;14(4):374-377.
41. Khalil SI, Gharieb K, El Haj M, Khalil M, Hakiem S. Prevalence of congenital heart disease among schoolchildren of Sahafa Town, Sudan. East Mediterr Health J. 1997;3(1):24-28. (Pubitemid 127468679)
42. Nieminen HP, Jokinen EV, Sairanen HI. Late results of pediatric cardiac surgery in Finland:a population-based study with 96% follow-up. Circulation. 2001;104(5):570-575.
43. Sani MU, Mukhtar-Yola M, Karaye KM. Spectrum of congenital heart disease in a tropical environment:an echocardiography study. J Natl Med Assoc. 2007;99(6):665-669. (Pubitemid 47012777)
44. Tefuarani N, Vince J, Hawker R, Sleigh A, Williams G. The medium-to-long-term outcome of Papua New Guinean children after cardiac surgery. Ann Trop Paediatr. 2004;24(1):65-74.
45. Adatia I, Barrow SE, Stratton PD, Ritter JM, Haworth SG. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. Br Heart J. 1994;72(5):452-456. (Pubitemid 24341551)
46. Adatia I, Barrow SE, Stratton PD, Miall-Allen VM, Ritter JM, Haworth SG. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Circulation. 1993;88(5 Pt 1):2117-2122.
47. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension:marker or mediator of disease? Ann Intern Med. 1991;114(6):464-469.
48. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg. 1993;106(3):473-478. (Pubitemid 23277619)
49. Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991;84(6):2280-2285.
50. Botney MD. Role of hemodynamics in pulmonary vascular remodeling:implications for primary pulmonary hypertension. Am J Respir Crit Care Med. 1999;159(2):361-364.
51. Rabinovitch M, Konstam MA, Gamble WJ, et al. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ Res. 1983;52(4):432-441. (Pubitemid 13091201)
52. O'Blenes SB, Fischer S, McIntyre B, Keshavjee S, Rabinovitch M. Hemodynamic unloading leads to regression of pulmonary vascular disease in rats. J Thorac Cardiovasc Surg. 2001;121(2):279-289.
53. Mata-Greenwood E, Meyrick B, Steinhorn RH, Fineman JR, Black SM. Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2003;285(1): L209-L221.
54. Mata-Greenwood E, Meyrick B, Soifer SJ, Fineman JR, Black SM. Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2003;285(1):L222-L231. (Pubitemid 36736485)
55. Wedgwood S, Devol JM, Grobe A, et al. Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res. 2007;61(1):32-36.
56. Lévy M, Maurey C, Celermajer DS, et al. Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. J Am Coll Cardiol. 2007; 49(7):803-810. (Pubitemid 46240714)
57. Smadja DM, Gaussem P, Mauge L, et al. Circulating endothelial cells:a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation. 2009;119(3):374-381.
58. Diller GP, van Eijl S, Okonko DO, et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation. 2008;117(23):3020-3030.
59. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. Circulation. 1958;18(4 pt 1): 533-547.
60. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease:a morphometric approach to pulmonary vascular disease. Circulation. 1978;58(6):1107-1122.
61. Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation. 1984;69(4): 655-667.
62. Haworth SG. Pulmonary vascular disease in ventricular septal defect:structural and functional correlations in lung biopsies from 85 patients, with outcome of intracardiac repair. J Pathol. 1987;152(3):157-168.
63. Haworth SG, Hislop AA. Pulmonary vascular development: normal values of peripheral vascular structure. Am J Cardiol. 1983;52(5):578-583.
64. Sreeram N, Petros A, Peart I, Arnold R. Progressive pulmonary hypertension after the arterial switch procedure. Am J Cardiol. 1994;73(8):620-621.
65. Kumar A, Taylor GP, Sandor GG, Patterson MW. Pulmonary vascular disease in neonates with transposition of the great arteries and intact ventricular septum. Br Heart J. 1993;69(5):442-445. (Pubitemid 23171122)
66. Maeno Y, Hornberger LK, Kamenir SA, et al. Prenatal features of restrictive foramen ovale and ductal constriction in D-transposition of the great arteries. Circulation. 1999; 99(9):1209-1214. (Pubitemid 29120093)
67. Soongswang J, Adatia I, Newman C, Smallhorn JF, Williams WG, Freedom RM. Mortality in potential arterial switch candidates with transposition of the great arteries. J Am Coll Cardiol. 1998;32(3):753-757.
68. Rudolph A. Congenital Diseases of the Heart:Clinical- Physiological Considerations. Armonk, New York :Futura; 2001 :703.
69. Rudolph AM. Aortopulmonary transposition in the fetus: speculation on pathophysiology and therapy. Pediatr Res. 2007;61(3):375-380.
70. Haworth SG. Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. Br Heart J. 1984;52(5):557-571.
71. Clarkson PM, Neutze JM, Wardill JC, Barratt-Boyes BG. The pulmonary vascular bed in patients with complete transposition of the great arteries. Circulation. 1976;53(3): 539-543.
72. Lakier JB, Stanger P, Heymann MA, Hoffman JI, Rudolph AM. Early onset of pulmonary vascular obstruction in patients with aortopulmonary transposition and intact ventricular septum. Circulation. 1975;51(5):875-880.
73. Keane JF, Ellison RC, Rudd M, Nadas AS. Pulmonary blood flow and left ventricular volumes in transposition of the great arteries and intact ventricular septum. Br Heart J. 1973;35(5):521-526.
74. Newfeld EA, Paul MH, Muster AJ, Idriss FS. Pulmonary vascular disease in transposition of the great vessels and intact ventricular septum. Circulation. 1979;59(3):525-530.
75. Kidd L, Rose V, Collins G, Keith J. The hemodynamics in ventricular septal defect in childhood. Am Heart J. 1965;70(6):732-738.
76. Weidman W, Blount S, DuShane J, et al. Clinical course in ventricular septal defect. Circulation. 1977;56(suppl l): I56-I69.
77. Yeager SB, Freed MD, Keane JF, Norwood WI, Castaneda AR. Primary surgical closure of ventricular septal defect in the first year of life:results in 128 infants. J Am Coll Cardiol. 1984;3(5):1269-1276.
78. Clarkson PM, Frye RL, DuShane JW, Burchell HB, Wood EH, Weidman WH. Prognosis for patients with ventricular septal defect and severe pulmonary vascular obstructive disease. Circulation. 1968;38(1):129-135.
79. Friedli B, Kidd BS, Mustard WT, Keith JD. Ventricular septal defect with increased pulmonary vascular resistance. Late results of surgical closure. Am J Cardiol. 1974;33(3):403-409.
80. Cartmill TB, DuShane JW, McGoon DC, Kirklin JW. Results of repair of ventricular septal defect. J Thorac Cardiovasc Surg. 1966;52(4):486-501.
81. Castañeda AR, Zamora R, Nicoloff DM, Moller JH, Hunt CE, Lucas RV. High-pressure, high-resistance ventricular septal defect. Surgical results of closure through right atrium. Ann Thorac Surg. 1971;12(1):29-38.
82. Sigmann JM, Perry BL, Gehrendt DM, Stern AM, Kirsh MM, Sloan HE. Ventricular septal defect:results after repair in infancy. Am J Cardiol. 1977;39(1):66-71.
83. Hallidie-Smith KA, Hollman A, Cleland WP, Bentall HH, Goodwin JF. Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease. Br Heart J. 1969;31(2):246-260.
84. Keith J. Ventricular septal defect. In:Keith J, Vlad P, Rowe RD, eds. Heart Disease in Infancy and Childhood. New York : Macmillan Publishing Co;1978 :320-379.
85. Moller JH, Patton C, Varco RL, Lillehei CW. Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960. Am J Cardiol. 1991;68(15): 1491-1497.
86. Hallidie-Smith KA, Wilson RS, Hart A, Zeidifard E. Functional status of patients with large ventricular septal defect and pulmonary vascular disease 6 to 16 years after surgical closure of their defect in childhood. Br Heart J. 1977;39(10):1093-1101. (Pubitemid 8191714)
87. Kulik TJ, Bass JL, Fuhrman BP, Moller JH, Lock JE. Exercise induced pulmonary vasoconstriction. Br Heart J. 1983;50(1):59-64.
88. Kannan BR, Sivasankaran S, Tharakan JA, et al. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance. Indian Heart J. 2003;55(2):161-166.
89. Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg. 1991;5(12):628-634.
90. Adatia I, Beghetti M. Early postoperative care of patients with pulmonary hypertension associated with congenital cardiac disease. Cardiol Young. 2009;19:315-319.
91. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. BMJ. 1958;2(5098): 701-709.
92. Neutze JM, Ishikawa T, Clarkson PM, Calder AL, Barratt- Boyes BG, Kerr AR. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. Am J Cardiol. 1989;63(5):327-331.
93. Balzer DT, Kort HW, Day RW, et al. Inhaled Nitric Oxide as a Preoperative Test(INOP Test I):the INOP Test Study Group. Circulation. 2002;106(12 suppl 1):I76-I81.
94. Eisenmenger V. Die angeborenes Defekt der Kammers-chiedewand des Herzen. Z Klin Med. 1897:32(suppl)1-28.
95. Brammell HL, Vogel JHK, Pryor R, Blount SG Jr. The Eisenmenger syndrome. A clinical and physiologic reappraisal. Am J Cardiol. 1971;28(6):679-692.
96. Post MC, Janssens S, Van de Werf F, Budts W. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Eur Heart J. 2004;25(18): 1651-1656.
97. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation . J Am Coll Cardiol. 1995;25(7):1652-1664.
98. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome . J Heart Lung Transplant. 1996;15(1 pt 1):100-105.
99. Budts W, Van Pelt N, Gillyns H, Gewillig M, Van De Werf F, Janssens S. Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome. Heart. 2001;86(5):553-558. (Pubitemid 32999869)
100. Gatzoulis MA, Beghetti M, GalièN, et al;BREATHE-5 Investigators. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome:results of the BREATHE-5 open-label extension study. Int J Cardiol. 2008; 127(1):27-32.
101. GalièN, Beghetti M, Gatzoulis MA, et al;Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome:a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006; 114(1):48-54.
102. Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol. 2008;129(2):163-171.
103. Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension:the UK Pulmonary Hypertension Service for Children 2001-2006. Heart. 2009; 95(4):312-317.
104. van der Merwe PL, Kalis N, Schaaf HS, Nel EH, Gie RP. Risk of pulmonary tuberculosis in children with congenital heart disease. Pediatr Cardiol. 1995;16(4):172-175.
105. Ifere OA, Aikhionbare HA, Yusuf U. Congenital heart disease masking pulmonary tuberculosis in children. East Afr Med J. 1989;66(6):414-418.
106. Lubega S, Zirembuzi GW, Lwabi P. Heart disease among children with HIV/AIDS attending the paediatric infectious disease clinic at Mulago Hospital. Afr Health Sci. 2005;5(3):219-226.
107. Bannerman C, Chitsike I. Cor pulmonale in children with human immunodeficiency virus infection. Ann Trop Paediatr. 1995;15(2):129-134.
108. Okeniyi J, Kuti B. Cerebral malaria in children with cyanotic heart diseases:the need for a closer look. Congenit Heart Dis. 2008;3(1):73-76.
109. Oster ME, Riehle-Colarusso T, Correa A. An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res A Clin Mol Teratol. 2010;88(1):1-8.
110. McCrindle BW, Wood MM, Collins GF, Wheatley B, Rowe RD. An increased incidence of total anomalous pulmonary venous drainage among aboriginal Canadians. Can J Cardiol. 1996; 12(1):81-85.
111. Du L, Sullivan CC, Chu D, et al. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med. 2003; 348(6):500-509. (Pubitemid 36159885)
112. Vaughan CJ, Basson CT. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. Am J Med Genet C Semin Med Genet. 2001;97(4):304-309.
113. Chen QH, Wang XQ, Qi SG. Cross-sectional study of congenital heart disease among Tibetan children aged from 4 to 18 years at different altitudes in Qinghai Province. Chin Med J(Engl). 2008;121(24):2469-2472.
114. Miao CY, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac anomalies at high altitude. J Am Coll Cardiol. 1988;12(1):224-228.
115. Penaloza D, Arias-Stella J, Sime F, Recavarren S, Marticorena E. The heart and pulmonary circulation in children at high altitudes:physiological, anatomical, and clinical observations. Pediatrics. 1964;34 :568-582.
116. Sime F, Banchero N, Peñaloza D, Gamboa R, Cruz J, Marticorena E. Pulmonary hypertension in children born and living at high altitudes. Am J Cardiol. 1963;11:143-149.
117. Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes:healthy highlanders and chronic mountain sickness. Circulation. 2007;115(9):1132-1146.
118. Soliman EZ, Juma H. Cardiac disease patterns in northern Malawi:epidemiologic transition perspective. J Epidemiol. 2008;18(5):204-208.
119. Yacoub MH. Establishing pediatric cardiovascular services in the developing world:a wake-up call. Circulation. 2007; 116(17):1876-1878.
120. Stolf NA. Congenital heart surgery in a developing country: a few men for a great challenge. Circulation. 2007;116(17): 1874-1875.
121. Larrazabal LA, Jenkins KJ, Gauvreau K, et al. Improvement in congenital heart surgery in a developing country: the Guatemalan experience. Circulation. 2007;116(17): 1882-1887.
122. Novick WM, Sandoval N, Lazorhysynets VV, et al. Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance. Ann Thorac Surg. 2005;79(1):21-28.